The amount of a protein linked to learning and memory in mice found in the spinal fluid may act as an early predictor of mild cognitive impairment (MCI) years before symptoms appear, according to a study of cognitively healthy adults.
A study of cognitively healthy adults has added to evidence that low spinal fluid levels of a protein associated with learning and memory in mice may serve as an early predictor of mild cognitive impairment (MCI) years before symptoms appear.
According to recent Alzheimer's research from UVA Health, increased light sensitivity may be responsible for "sundowning," or the exacerbation of symptoms in the late afternoon, as well as for sleep disturbances that are thought to hasten the disease's progression.
According to a UCLA Health study, Kundalini yoga, a type of yoga that focuses on breathing, meditation, and mental visualisation, appeared beneficial for older women who had risk factors for Alzheimer's disease and were concerned about episodes of memory deterioration.
At the International Alzheimer's Congress (AAIC) in Amsterdam, new diagnostic standards for Alzheimer's disease were unveiled by medical professionals and academics from around the globe.
Espresso, whether savoured on its own or combined into a latte, Americano, or even a martini, delivers an ultra-concentrated rush of caffeine to coffee lovers. But it could be doing more than just wake you awake. According to preliminary in vitro laboratory testing, espresso components can s
A research team has demonstrated that the disease can be detected before symptoms appear using a spinal fluid test. The findings were published in Nature Medicine, where the researchers also show that a reduced sense of smell is strongly linked to Lewy body disease even before other obvious
This study concentrated on the protein p38. Many labs have been studying this protein as a potential target for medication development to treat Alzheimer's disease and other neuroinflammatory disorders.
New guidelines for diagnosing Alzheimer's disease developed by clinicians and researchers from around the world were presented at the International Alzheimer's Congress (AAIC) in Amsterdam.